STAT3 and glioblastoma: Treatment with the TM5441 rescued the muscle atrophy phenotype in IR CM or exosome treatment group (Figure 7A,B, Figure S6B–I), and also resulted in decreased activation of STAT3 as compared with the GBM CM- and exosome-treated groups (Figure 7A,B, Figure S6B–I).